19-20 March 2019
Beurs van Berlage, Amsterdam

Market Access, Pricing, Value and Evidence

SPONSOR NOW

DOWNLOAD PROSPECTUS

KEYNOTE PLENARIES

EVIDENCE

RARE DISEASES

PRICING & MODELLING

NOVEL THERAPEUTICS

BIG DATA, AI & DIGITAL
Market Access, Pricing, Value and Evidence

SPONSOR NOW

DOWNLOAD PROSPECTUS

KEYNOTE PLENARIES

EVIDENCE

RARE DISEASES

PRICING & MODELLING

NOVEL THERAPEUTICS

BIG DATA, AI & DIGITAL

About Pharma Pricing & Market Access Congress

Discuss pricing, patient centricity and global market access all in one place. With collaboration high on the agenda, World Pharma Pricing and Market Access gives you excellent opportunities to hear from payers, pharma, patient led organisations and providers.

Attend Europe’s largest, most respected market access and pricing conference to benchmark your strategic decision making. Hear from an unprecedented number of international payers at our congress as we celebrate 11 successful years in 2019. Learn how to prepare your market access strategy for the ever changing global healthcare market and understand the diverse payer landscape and how to influence decision making with insight from key payer organisations.

It’s about getting the right drug, to the right patient, at the right cost and achieving maximum reimbursement success.

DOWNLOAD PROSPECTUS

"Great networking; very useful to hear from a mix of pharma companies and payers about market access and evidence requirements”

Head Global Pricing & Market Access, Vifor Pharma

2018 Keynote Speakers

Carla Deakin
Associate Director, Office for Market Access
NICE

Andrew Dillon
Chief Executive
National Institute for Health and Care Excellence

Sebastien Le Roux
VP, Global Market Access & Healthcare Solutions
Glaxo Smith Kline Inc
Farzana Malik
Vice President Market Access
Vicarius Pharma

Thomas Mueller
Head of Pharmaceuticals
G-BA

Jeff Myers
CEO
Medicaid Health Plans of America
Alexander Natz
Secretary General
EUCOPE

Tanya Potashnik
Director Policy & Economic Analysis, Patented Medicine Prices Review Board
Goverment Of Canada

Anne Toni Rodgers
Former Global Head Operations Payer And Real World Evidence
AstraZeneca
Gundula Schneidewind
Managing Director
Takeda Belgium

Rob Scott
Chief Medical Officer, VP, Head of Development
AbbVie

Keiko Tone
VP Market Access
Shionogi Limited
Shameer Khader
Program Director (Healthcare Data Science and Bioinformatics)
Northwell Health

Diane Munch
Head of Global Pricing, Patient & Health Impact
Pfizer

Katja Berg
Vice President of Operations and Payers Intelligence
Sanofi
Patrick Hopkinson
Executive Director, WWHEOR Markets
Bristol-Myers Squibb

Britta Paschen
VP, Head of Global Evidence and Value Development
Merck KGaA

Etienne Jousseaume
Head Market Access Cell & Gene Therapies Europe
Novartis Oncology